Growth factor receptor tyrosine kinases: Cell adhesion kinase family suggests a novel signaling mechanism in cancer

Cancer Investigation

Volumn 18, Issue 6, 2000, Pages 544-554

  Weiner, Howard L ^a,b   Zagzag, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ACTININ; CADHERIN; COLLAGEN; COLLAGENASE; DISCOIDIN; EPHRIN; FIBRONECTIN; FOCAL ADHESION KINASE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HLA ANTIGEN; HORMONE; IMMUNOGLOBULIN; INTEGRIN; MEMBRANE PROTEIN; MESSENGER RNA; NEUROTRANSMITTER; NEUROTROPHIN RECEPTOR; PAXILLIN; PROTEIN P53; PROTEIN S; PROTEIN TYROSINE KINASE; TALIN; VINCULIN; VITRONECTIN;

APOPTOSIS; BRAIN TUMOR; CLINICAL TRIAL; GENE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033915130     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009012194     Document Type: Review

References (99)

1. Weiner HL: The role of growth factor receptors in central nervous system development and neoplasia. Neurosurgery 37:179-193, 1995.
2. Clark EA, Brugge JS: Integrins and signal transduction pathways: the road taken. Science 268:233-239, 1995.
3. Shrivastava A, Radziejewski C, Campbell E, et al: An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1:25-34, 1997.
4. Vogel W, Gish GD, Alves F, et al: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1:13-23. 1997.
5. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391, 1992.
6. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990.
7. Chao MV: Growth factor signaling: where is the specificity? Cell 68:995-997, 1992.
8. Schlessinger J: Direct binding and activation of receptor tyrosine kinases by collagen. Cell 91:869-872, 1997.
9. Hanks SK, Quinn AM, Hunter T: The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52, 1988.
10. Weiner HL, Rothman M, Miller DC, et al: Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases. Pediatr Neurosurg 25:64-72, 1996.
11. Wilks AF, Kurban RR, Hovens CM, et al: The application of the polymerase chain reaction to cloning members of the protein tyrosine kinase family. Gene 85:67-74, 1989.
12. Stitt TN, Conn G, Gore M. et al: The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80:661-670, 1995.
13. Klein R, Jing SQ, Nanduri V, et al: The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65:189-197, 1991.
14. Beckmann MP, Cerretti DP, Baum P, et al: Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J 13:3757-3762, 1994.
15. Cheng HJ, Flanagan JG: Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases. Cell 79:157-168, 1994.
16. Davis S, Gale NW, Aldrich TH, et al: Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266:816-819, 1994.
17. Bartley TD, Hunt RW, Welcher AA, et al: B61 is a ligand for the ECK receptor protein-tyrosine kinase. Nature 368:558-560, 1994.
18. Holland SJ, Gale NW, Mbamalu G, et al: Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383:722-725, 1996.
19. Varnum BC, Young C, Elliott G, et al: Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 373:623-626, 1995.
20. Glass DJ, Bowen DC, Stitt TN, et al: Agrin acts via a MuSK receptor complex. Cell 85:513-523, 1996.
21. Jing S, Wen D, Yu Y, et al: GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124, 1996.
22. Treanor JJ, Goodman L, de SF, et al: Characterization of multicomponent receptor for GDNF [see comments] Nature 382:80-83, 1996.
23. Davis S, Aldrich TH, Jones PF, et al: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [see comments] Cell 87:1161-1169, 1996.
24. Maisonpierre PC, Suri C, Jones PF, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [see comments] Science 277:55-60, 1997.
25. Chao MV: Neurotrophin receptors: a window into neuronal differentiation. Neuron 9:583-593, 1992.
26. Lai C, Lemke G: An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6:691-704, 1991.
27. Sanchez MP, Tapley P, Saini SS, et al: Multiple tyrosine protein kinases in rat hippocampal neurons: isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain. Proc Natl Acad Sci USA 91:1819-1823, 1994.
28. Yang X, Chung D, Cepko CL: Molecular cloning of the murine JAKI protein tyrosine kinase and its expression in the mouse central nervous system. J Neurosci 13:3006-3017, 1993.
29. Cross M, Dexter TM: Growth factors in development, transformation, and tumorigenesis. Cell 64:271-280, 1991.
30. Kilpatrick TJ, Bartlett PF: Cloning and growth of multipotential neural precursors: requirements for proliferation and differentiation. Neuron 10:255-265, 1993.
31. Rubin GM: Signal transduction and the fate of the R7 photoreceptor in Drosophila. Trends Genet 7:372-377, 1991.
32. Sajjadi FG, Pasquale EB: Five novel avian Eph-related tyrosine kinases are differentially expressed. Oncogene 8:1807-1813, 1993.
33. Perez JL, Shen X, Finkernagel S, et al: Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain. Oncogene 9:211-219, 1994.
34. Perez JL, Jing SQ, Wong TW: Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. Oncogene 12:1469-1477, 1996.
35. Lai C, Lemke G: Structure and expression of the Tyro 10 receptor tyrosine kinase. Oncogene 9:877-883, 1994.
36. Zerlin M, Julius MA, Goldfarb M: NEP: a novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia. Oncogene 8:2731-2739, 1993.
37. Resnicoff M, Sell C, Rubini M, et al: Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54:2218-2222, 1994.
38. Reynolds BA, Tetzlaff W, Weiss S: A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12:4565-4574, 1992.
39. Vescovi AL, Reynolds BA, Fraser DD, et al: bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 11:951-966, 1993.
40. Turner DL, Cepko CL: A common progenitor for neurons and glia persists in rat retina late in development. Nature 328:131-136, 1987.
41. Raff MC: Glial cell diversification in the rat optic nerve. Science 243:1450-1455, 1989.
42. Di Marco E, Cutuli N, Guerra L, et al: Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. J Biol Chem 268:24290-24295, 1993.
43. Martin ZD, Hughes SH, Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319:743-748, 1986.
44. Di Fiore P, Pierce JH, Fleming TP, et al: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51:1063-1070, 1987.
45. Doolittle RF, Hunkapiller MW, Hood LE, et al: Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221:275-277, 1983.
46. Downward J, Yarden Y, Mayes E, et al: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521-527, 1984.
47. Morrison RS, Yamaguchi F, Bruner JM, et al: Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 54:2794-2799, 1994.
48. Zagzag D, Miller DC, Sato Y, et al: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50:7393-7398, 1990.
49. Wong AJ, Bigner SH, Bigner DD, et al: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Nat Acad Sci USA 84:6899-6903, 1987.
50. Plate KH, Breier G, Weich HA, et al: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848, 1992.
51. Millauer B, Shawver LK, Plate KH, et al: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579, 1994.
52. Hermanson M, Funa K, Hartman M, et al: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213-3219, 1992.
53. Glick RP, Gettleman R, Patel K, et al: Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery 24:791-797, 1989.
54. Libermann TA, Nusbaum HR, Razon N, et al: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144-147, 1985.
55. Ekstrand AJ, James CD, Cavenee WK, et al: Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164-2172, 1991.
56. Fleming TP, Saxena A, Clark WC, et al: Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52:4550-4553, 1992.
57. Morrison RS, Gross JL, Herblin WF, et al: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line [published erratum appears in Cancer Res 1990 Aug 1; 50(15):4825] Cancer Res 50:2524-2529, 1990.
58. Johnson JD, Edman JC, Rutter WJ: A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proc Natl Acad Sci USA 90:5677-5681, 1993.
59. Karn T. Holtrich U, Brauninger A, et al: Structure, expression and chromosomal mapping of TKT from man and mouse: a new subclass of receptor tyrosine kinases with a factor VIII- like domain. Oncogene 8:3433-3440, 1993.
60. Alves F, Vogel W, Mossie K, et al: Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 10:609-618, 1995.
61. Edelhoff S, Sweetser DA, Disteche CM: Mapping of the NEP receptor tyrosine kinase gene to human chromosome 6p21.3 and mouse chromosome 17C. Genomics 25:309-311, 1995.
62. Playford MP, Butler RJ, Wang XC, et al: The genomic structure of discoidin receptor tyrosine kinase. Genome Res 6:620-627, 1996.
63. Sakuma S, Saya H, Tada M, et al: Receptor protein tyrosine kinase DDR is up-regulated by p53 protein. FEBS Lett 398:165-169, 1996.
64. Sakuma S, Saya H, Ijichi A, et al: Radiation induction of the receptor tyrosine kinase gene Ptk-3 in normal rat astrocytes. Radiat Res 143:1-7, 1995.
65. Barker KT, Martindale JE, Mitchell PJ, et al: Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours. Oncogene 10:569-575, 1995.
66. Nemoto T, Ohashi K, Akashi T, et al: Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology 65: 195-203, 1997.
67. Hynes RO: Integrins: versitality, modulation and signaling in cell adhesion. Cell 69:11-25, 1992.
68. Plopper G, McNamee H, Dike L, et al: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6:1349-1365, 1995.
69. Burridge K, Turner CE, Romer LH: Tyrosine phosphorylation of pazillin and 125FAK acompanies cell adhesion to extracellular matrix: a role in cytoskelelal assembly. J Cell Biol 119:893-903, 1992.
70. Tahiliani PD, Singh L, Auer KL, et al: The role of conserved amino acid motifs within the integrin beta-3 cytoplasmic domain in triggering focal adhesion kinase phosphorylation. J Biol Chem 272:7892-7898, 1995.
71. Richardson A, Parsons JT: A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125 FAK. Nature 380:538-540, 1996.
72. Nojima Y, Morino N, Mimura T, et al: Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, an Src homology 3-containing molecule having multiple Src homology 2-binding motifs. J Biol Chem 270:15398-15402, 1995.
73. Vuori K, Hirai H, Aizawa S, et al: Induction of p130Cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol Cell Biol 16:2606-2613, 1996.
74. Polte TR, Hanks SK: Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proc Natl Acad Sci USA 92:10678-10682, 1998.
75. Ilic D, Furuta Y, Kanazawa S, et al: Reduced cell motilily and enhanced focal adhesion contact formation in cell from FAK-deficient mice. Nature 377:539-544, 1995.
76. Gilmore AP, Romer LH: Inhibition of focal adhesion kinase (FAK) signaling focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7:1209-1224, 1996.
77. Owens LV, Xu L, Craven RJ, et al: Overexpression of focal adhesion kinase (pp125FAK) in invasive human tumors. Cancer Res 55:2752-2755, 1995.
78. Schaller M, Parsons T: Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 6:705-710, 1994.
79. Sankar S, Mahooti-Brooks N, Hu G, et al: Modulation of cell spreading and migration by pp125 FAK phosphorylation. Am J Pathol 147:601-608, 1995.
80. Friedlander D, Zagzag D, Shiff B, et al: Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade, and involve alpha-v and beta-1 integrins. Cancer Res 56:1939-1947, 1996.
81. Paulus W, Baur I, Beuller AS, et al: Diffuse brain invasion of glioma cells requires beta-1 integrins. Lab Invest 75:819-826, 1996.
82. Zheng DQ, Woodard AS, Fornaro M, et al: Prostatic carcinoma cell migration via alpha-v-beta-3 integrin is modulated by it focal adhesion kinase pathway. Cancer Res 59:1655-1664, 1999.
83. Xu LH, Owens LV, Sturge GC, et al: Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Diff 7:413-418, 1996.
84. Frisch SM, Vouri K, Ruoslahti E, et al: Control of adhesion dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799, 1996.
85. Alvarez, RJ, Gips SJ, Moldovan N, et al: 17Beta-estradiol inhibits Biochem Biophys Res Commun 237:372-381, 1997.
86. Frisch SM, Ruoslathi E: Integrins and annexes. Curr Opin Cell Biol 9:701-706, 1997.
87. Romer LH, McLean N, Turner CE, et al: Tyrosine kinase cativity, cytoskeletal organization, and motility in human vascular endothelial cells. Mol Biol Cell 5:349-361, 1994.
88. Tremblay L, Hauck W, Aprikian AG, et al: Focal adhesion kinase pp125FAK expression, activation and association with paxillian and p50CSK in human metastatic prostate carcinoma. Int J Cancer 68:164-171, 1996.
89. Filardo EJ, Brooks PC, Deming SI, et al: Requirement of the NPXY motif in the integrin beta-3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J Cell Biol 130:1-10, 1995.
90. Cannistra SA, Ottensmeier C, Niloff J, et al: Expression and function of beta-1 and alpha-v-beta-3 integrins in ovarian cancer. Gynecol Oncol 58:216-225, 1995.
91. Liapis H, Flath A, Kitazawa S: Integrin alph-v-beta-3 expression by bone-residing breast cancer metastases Diagn Mol Pathol 5: 127-135, 1996.
92. Albelda SM, Mette SA, Elder DE, et al: Integrin distribution in malignant melanoma: association of the beta-3 subunit with tumor progression. Cancer Res 50:6757-6764, 1990.
93. Gehlsen KR, Davis GE, Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metast 10:111-120, 1992.
94. Zagzag D, Friedlander DR, Grumet M, et al: Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg (in press).
95. Vogel W, Gish GD, Alves F, et al: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1:13-23, 1997.
96. Berk BC: Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J Am Soc Nephrol 11:62-68, 1999.
97. Gu J, Tamura M, Yamada KM, et al: Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143:1375-1383, 1998.
98. Tamura M, Gu J, Matsumoto K, et al: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617, 1998.
99. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39:235-250, 1996.